Canada · Delayed Price · Currency is CAD XORTX Therapeutics Statistics
Total Valuation
TSXV:XRTX has a market cap or net worth of CAD 5.57 million. The enterprise value is 3.99 million.
| Market Cap | 5.57M |
| Enterprise Value | 3.99M |
Important Dates
The next estimated earnings date is Thursday, March 26, 2026.
| Earnings Date | Mar 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:XRTX has 6.96 million shares outstanding. The number of shares has increased by 53.07% in one year.
| Current Share Class | 6.96M |
| Shares Outstanding | 6.96M |
| Shares Change (YoY) | +53.07% |
| Shares Change (QoQ) | +28.20% |
| Owned by Insiders (%) | 2.00% |
| Owned by Institutions (%) | 4.01% |
| Float | 6.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 2.03 |
| P/TBV Ratio | 2.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.47 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.62, with a Debt / Equity ratio of 0.03.
| Current Ratio | 1.62 |
| Quick Ratio | 1.45 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -94.63% and return on invested capital (ROIC) is -71.41%.
| Return on Equity (ROE) | -94.63% |
| Return on Assets (ROA) | -45.32% |
| Return on Invested Capital (ROIC) | -71.41% |
| Return on Capital Employed (ROCE) | -122.37% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.21% in the last 52 weeks. The beta is -0.12, so TSXV:XRTX's price volatility has been lower than the market average.
| Beta (5Y) | -0.12 |
| 52-Week Price Change | -45.21% |
| 50-Day Moving Average | 0.97 |
| 200-Day Moving Average | 1.22 |
| Relative Strength Index (RSI) | 44.00 |
| Average Volume (20 Days) | 9,888 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.36M |
| Pretax Income | -2.71M |
| Net Income | -2.71M |
| EBITDA | -3.40M |
| EBIT | -3.36M |
| Earnings Per Share (EPS) | -0.69 |
Balance Sheet
The company has 1.66 million in cash and 82,311 in debt, with a net cash position of 1.58 million or 0.23 per share.
| Cash & Cash Equivalents | 1.66M |
| Total Debt | 82,311 |
| Net Cash | 1.58M |
| Net Cash Per Share | 0.23 |
| Equity (Book Value) | 2.75M |
| Book Value Per Share | 0.53 |
| Working Capital | 724,402 |
Cash Flow
| Operating Cash Flow | -4.11M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSXV:XRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -53.07% |
| Shareholder Yield | -53.07% |
| Earnings Yield | -48.60% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 14, 2023. It was a reverse split with a ratio of 0.1111111.
| Last Split Date | Nov 14, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.1111111 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |